SCHEMBL3977014

SCHEMBL3977014

CN(C)C=CC(=O)c1ccc(C(=O)NCC(C)(C)CN(C)C)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 5/20 0.49
GAA P10253 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.40
TSHR P16473 1/20 0.40
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
MAPT P10636 5/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
RECQL P46063 1/20 0.35
POLB P06746 1/20 0.35
KCNA5 P22460 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977008 1.00 ALDH1A1 (0.49) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3974029 0.82 KDM4E (0.46) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3977024 0.81 MAPK1 (0.62) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3977017 0.81 MAPK1 (0.62) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3971128 0.75 HDAC3 (0.55) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3978597 0.75 HDAC3 (0.55) ALDH1A1KDM4EGAAKMT2AMAPK1
SCHEMBL3973421 0.74 HDAC3 (0.58) ALDH1A1KDM4EGAAKMT2AMAPT
SCHEMBL3973430 0.74 HDAC3 (0.58) ALDH1A1KDM4EGAAKMT2AMAPT
SCHEMBL6383504 0.73 KDM4E (0.42) ALDH1A1KDM4EGAAMAPK1TSHR
SCHEMBL13992633 0.72 RAB9A (0.64) ALDH1A1KDM4EGAAKMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907385-A4 COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2009-05-06 EP disclosed
US-20080194561-A1 carboxyamide thiophenes and medicaments containing the same as well as processes for the preparation and use of such compounds, compositions and medicaments, particularly in diseases associated with inappropriate Aurora activity. SMITHKLINE BEECHAM CORPORATION 2008-08-14 US disclosed
EP-1907385-A2 COMPOUNDS SmithKline Beecham Corporation (US) 2008-04-09 EP disclosed
WO-2007018941-A2 PYRIMIDYL-THIOPHENE DERIVATIVES SMITHKLINE BEECHAM CORPORATION (US) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194561-A1 carboxyamide thiophenes and medicaments containing the same as well as processes for the preparation and use of such compounds, compositions and medicaments, particularly in diseases associated with inappropriate Aurora activity. AURKA, AURKC, AURKB ALDH1A1 3516/4885KDM4E 882/4885GAA 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.